blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1689419

EP1689419 - PHARMACEUTICAL COMPOSITIONS INCLUDING LOW DOSAGES OF DESMOPRESSIN [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  13.01.2023
Database last updated on 24.08.2024
Most recent event   Tooltip13.01.2023Change - applicant 
13.01.2023Withdrawal of applicationpublished on 15.02.2023  [2023/07]
Applicant(s)For all designated states
Ferring B.V.
Polarisavenue 144
2132 JX Hoofddorp / NL
[N/P]
Former [2014/07]For all designated states
Reprise Biophamaceutics, LLC
120 North Main Street, Suite 400
New York, NY 10956 / US
Former [2011/35]For all designated states
Allergan, Inc.
2525 Dupont Drive
Irvine, CA 92612 / US
Former [2008/44]For all designated states
Reprise Biopharmaceutics, LLC
120 North Main Street Suite 400
New York NY 10956 / US
Former [2006/33]For all designated states
Fein, Seymour N.
476 Canoe Hill Road
New Canaan, CT 06840 / US
Inventor(s)01 / Fein, Seymour N.
476 Canoe Hill Road
New Canaan CT 06840 / US
 [2008/44]
Former [2006/33]01 / see applicant
...
Representative(s)Prins, Hendrik Willem
Arnold & Siedsma
Bezuidenhoutseweg 57
2594 AC The Hague / NL
[N/P]
Former [2011/43]Kupecz, András Ferenc
Simmons & Simmons LLP
Claude Debussylaan 247
1082 MC Amsterdam / NL
Former [2011/35]Kupecz, András Ferenc
Simmons & Simmons
WTC H Tower
P.O. Box 79023
1070 NB Amsterdam / NL
Former [2009/28]Lock, Graham James
Fry Heath & Spence LLP The Gables Massetts Road Horley
Surrey RH6 7DQ / GB
Former [2009/26]Lock, Graham James
Fry Heath & Spence LLP The Gables Massetts Road Horley
Surrey RH6 7DQ / GB
Former [2006/33]Elsy, David, et al
Withers & Rogers LLP Goldings House, 2 Hays Lane
London SE1 2HW / GB
Application number, filing date03781836.610.11.2003
[2006/33]
WO2003US35662
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005046707
Date:26.05.2005
Language:EN
[2005/21]
Type: A1 Application with search report 
No.:EP1689419
Date:16.08.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 26.05.2005 takes the place of the publication of the European patent application.
[2006/33]
Search report(s)International search report - published on:US26.05.2005
(Supplementary) European search report - dispatched on:EP11.12.2008
ClassificationIPC:A61K38/11, A61P13/00
[2011/05]
CPC:
A61K9/2018 (EP); A61K38/095 (EP); A61K9/0019 (EP);
A61K9/0056 (EP); A61P13/00 (EP); A61P13/02 (EP);
A61P13/10 (EP); A61P7/04 (EP) (-)
Former IPC [2009/02]A61K38/11
Former IPC [2006/33]A61K38/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2006/33]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT NIEDRIGEN DOSEN VON DESMOPRESSIN[2006/33]
English:PHARMACEUTICAL COMPOSITIONS INCLUDING LOW DOSAGES OF DESMOPRESSIN[2006/33]
French:COMPOSITIONS PHARMACEUTIQUES COMPORTANT DE LA DESMOPRESSINE FAIBLEMENT DOSEE[2006/33]
Entry into regional phase02.06.2006National basic fee paid 
02.06.2006Search fee paid 
02.06.2006Designation fee(s) paid 
02.06.2006Examination fee paid 
Examination procedure07.06.2005Request for preliminary examination filed
International Preliminary Examining Authority: US
29.05.2006Amendment by applicant (claims and/or description)
02.06.2006Examination requested  [2006/33]
17.03.2009Despatch of a communication from the examining division (Time limit: M04)
12.06.2009Reply to a communication from the examining division
12.04.2010Despatch of a communication from the examining division (Time limit: M04)
08.07.2010Reply to a communication from the examining division
16.11.2010Despatch of a communication from the examining division (Time limit: M02)
20.12.2010Reply to a communication from the examining division
07.02.2011Communication of intention to grant the patent
06.04.2011Fee for grant paid
06.04.2011Fee for publishing/printing paid
02.01.2023Application withdrawn by applicant  [2023/07]
Appeal following examination30.07.2012Appeal received No.  J0017/12
30.07.2012Statement of grounds filed
13.11.2013Result of appeal procedure: allowance of appeal
05.05.2017Appeal received No.  J0004/17
13.11.2013Date of oral proceedings
27.11.2013Minutes of oral proceedings despatched
16.05.2018Date of oral proceedings
11.06.2018Minutes of oral proceedings despatched
Divisional application(s)EP11000464.5  / EP2322194
EP11000465.2  / EP2322195
EP11000466.0  / EP2322196
EP11000467.8  / EP2322197
EP11000468.6  / EP2322198
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.03.2009
Fees paidRenewal fee
02.06.2006Renewal fee patent year 03
27.11.2006Renewal fee patent year 04
27.11.2007Renewal fee patent year 05
25.11.2008Renewal fee patent year 06
25.11.2009Renewal fee patent year 07
24.11.2010Renewal fee patent year 08
23.11.2011Renewal fee patent year 09
26.11.2012Renewal fee patent year 10
27.11.2013Renewal fee patent year 11
26.11.2014Renewal fee patent year 12
30.11.2015Renewal fee patent year 13
28.11.2016Renewal fee patent year 14
27.11.2017Renewal fee patent year 15
27.11.2018Renewal fee patent year 16
27.11.2019Renewal fee patent year 17
27.11.2020Renewal fee patent year 18
18.11.2021Renewal fee patent year 19
Penalty fee
Additional fee for renewal fee
30.11.202220   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Stay/Interruption28.03.2011Stay of proceedings[2011/19]
28.03.2011Stay of proceedings[2022/43]
02.01.2023Resumption of proceedings[2022/43]
Documents cited:Search[E]WO03094886  (FERRING BV [NL], et al) [E] 1-16 * Examples 1-6, Comparative example 1; page 26, line 1 - page 28, line 2 *;
 [E]WO2004041153  (FEIN SEYMOUR H [US]) [E] 1-16* Examples 1-6, Comparative example 1; page 27 - page 28 *;
 [X]  - AGNOLI G C ET AL, "Low-dose desmopressin infusion: renal action in healthy women in moderate salt retention and depletion, and interactions with prostanoids.", PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, (200210), vol. 67, no. 4, ISSN 0952-3278, pages 263 - 273, XP002505856 [X] 1-4,7-16 * abstract * * page 265, column L, line 10 - line 15 *

DOI:   http://dx.doi.org/10.1054/PLEF.428
 [X]  - GROSSMAN A ET AL, "TWO NEW MODES OF DESMOPRESSIN (DDAVP) ADMINISTRATION", BRITISH MEDICAL JOURNAL, LONDON, GB, (19800517), vol. 280, no. 6225, ISSN 0267-0623, page 1215, XP009003428 [X] 1-16 * the whole document *
 [X]  - JANKNEGT ET AL, "Oral Desmopressin as a New Treatment Modality for Primary Nocturnal Enuresis in Adolescents and Adults: A Double-Blind, Randomized, Multicenter Study", JOURNAL OF UROLOGY, BALTIMORE, MD, US, (19970201), vol. 157, no. 2, ISSN 0022-5347, pages 513 - 517, XP005573964 [X] 1-16 * abstract *

DOI:   http://dx.doi.org/10.1016/S0022-5347(01)65190-5
International search[Y]US4285858  (CORT JOSEPH H, et al);
 [Y]US5500413  (LARSSON KRISTER [SE], et al);
 [Y]US5990273  (ANDERSSON LARS HENRIK HARALD [SE], et al);
 [Y]US5989835  (DUNLAY R TERRY [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.